Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Brazil / NCT07490249
Starting soon Not applicable

Effects of a 12-Week Recreational Football Program on Physical Activity Determinants in Adolescents

NCT07490249 · tracked via the Priya Life Science Brazil tracker
Phase
Not applicable
Started
2026-03
Last updated
2026-03-24

Condition(s) studied

Physical Inactivity

Investigational drug(s) / intervention(s)

Recreational Football Program

Recreational Football Program: The intervention consists of a 12-week recreational football program delivered twice per week at the university's outdoor soccer field. Each 60-minute session includes a 10-minute warm-up followed by 50 minutes of small-sided, game-based football activities. Sessions are led by two trained coaches and an assistant under the supervision of the principal investigator. Heart rate is monitored using Polar H10 sensors, and a subsample of participants is tracked with GPS devices (GPEXE System) to quantify total distance and intensity zones. At the end of each session, participants report ratings of perceived exertion (Borg CR-10 Scale) and exercise enjoyment, providing immediate physiological and psychological response markers.

Study summary

Randomized controlled trial assessing the effects of a 12-week recreational football program on behavioral, psychosocial, environmental, and physical determinants of physical activity in male adolescents aged 10-13 years.

Eligibility

Sex
MALE
Min age
10 Years
Max age
13 Years
Healthy volunteers
Accepted
Inclusion Criteria: * male adolescents; * age 10-13 years; * medical clearance for physical activity; * availability for 12-week intervention. Exclusion Criteria: * presence of any clinical diagnosis that may interfere the performance of assessments or the intervention (including musculoskeletal, neurological, vascular, pulmonary, or cardiac disorders); * attendance \< 85% of sessions (intervention group).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
State University Of Rio de Janeiro Rio de Janeiro Rio de Janeiro

More Hospital Universitario Pedro Ernesto trials in Brazil

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07490249 on ClinicalTrials.gov ↗ ← All trials in Brazil